Systems biology-embedded target validation: improving efficacy in drug discovery
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systems biology-embedded target validation: improving efficacy in drug discovery
Authors
Keywords
-
Journal
Wiley Interdisciplinary Reviews-Systems Biology and Medicine
Volume 6, Issue 1, Pages 1-11
Publisher
Wiley
Online
2013-11-08
DOI
10.1002/wsbm.1253
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
- (2013) Craig E. Wheelock et al. EUROPEAN RESPIRATORY JOURNAL
- Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it
- (2013) Douglas B. Kell FEBS Journal
- Priorities for improving drug research, development and regulation
- (2013) Susan R. Forda et al. NATURE REVIEWS DRUG DISCOVERY
- Systems medicine: helping us understand the complexity of disease
- (2013) D. Vandamme et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmatics
- (2012) Diego Diez et al. BMC Medical Genomics
- Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing
- (2012) Gary R Mirams et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- Signalling by protein phosphatases and drug development: a systems-centred view
- (2012) Lan K. Nguyen et al. FEBS Journal
- Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
- (2012) Arvin C. Dar et al. NATURE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging real-time technologies in molecular medicine and the evolution of integrated ‘pharmacomics’ approaches to personalized medicine and drug discovery
- (2012) Elizabeth A. Milward et al. PHARMACOLOGY & THERAPEUTICS
- Aspirin Inhibits Colon Cancer Cell and Tumor Growth and Downregulates Specificity Protein (Sp) Transcription Factors
- (2012) Satya Pathi et al. PLoS One
- Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
- (2012) Elliott Antman et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
- (2011) Arvin C. Dar et al. Annual Review of Biochemistry
- Teratogenic effects of thalidomide: molecular mechanisms
- (2011) Takumi Ito et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Prediction of Survival by Neutropenia According To Delivery Schedule of Oxaliplatin–5-Fluorouracil–Leucovorin for Metastatic Colorectal Cancer in a Randomized International Trial (EORTC 05963)
- (2011) Pasquale F. Innominato et al. CHRONOBIOLOGY INTERNATIONAL
- What makes a good drug target?
- (2011) Isabella Gashaw et al. DRUG DISCOVERY TODAY
- Trends in the exploitation of novel drug targets
- (2011) Mathias Rask-Andersen et al. NATURE REVIEWS DRUG DISCOVERY
- Phase II failures: 2008–2010
- (2011) John Arrowsmith NATURE REVIEWS DRUG DISCOVERY
- Phase III and submission failures: 2007–2010
- (2011) John Arrowsmith NATURE REVIEWS DRUG DISCOVERY
- Drug Inhibition Profile Prediction for NFκB Pathway in Multiple Myeloma
- (2011) Huiming Peng et al. PLoS One
- A Computational Model to Predict the Effects of Class I Anti-Arrhythmic Drugs on Ventricular Rhythms
- (2011) J. D. Moreno et al. Science Translational Medicine
- Drug-target network in myocardial infarction reveals multiple side effects of unrelated drugs
- (2011) Francisco J. Azuaje et al. Scientific Reports
- A Combined Experimental and Mathematical Approach for Molecular-based Optimization of Irinotecan Circadian Delivery
- (2011) Annabelle Ballesta et al. PLoS Computational Biology
- A Systems Biology Approach Identifies Molecular Networks Defining Skeletal Muscle Abnormalities in Chronic Obstructive Pulmonary Disease
- (2011) Nil Turan et al. PLoS Computational Biology
- Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
- (2010) J A DiMasi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Rational approaches to targeted polypharmacology: creating and navigating protein–ligand interaction networks
- (2010) James T Metz et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development
- (2010) Alastair J Barr Future Medicinal Chemistry
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- Signalling ballet in space and time
- (2010) Boris N. Kholodenko et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- PROMISCUOUS: a database for network-based drug-repositioning
- (2010) J. von Eichborn et al. NUCLEIC ACIDS RESEARCH
- The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier
- (2010) O. E. Sturm et al. Science Signaling
- Systems Biology Reveals New Strategies for Personalizing Cancer Medicine and Confirms the Role of PTEN in Resistance to Trastuzumab
- (2009) D. Faratian et al. CANCER RESEARCH
- A systems biological approach suggests that transcriptional feedback regulation by dual-specificity phosphatase 6 shapes extracellular signal-related kinase activity in RAS-transformed fibroblasts
- (2009) Nils Blüthgen et al. FEBS Journal
- Global Effects of Kinase Inhibitors on Signaling Networks Revealed by Quantitative Phosphoproteomics
- (2009) Cuiping Pan et al. MOLECULAR & CELLULAR PROTEOMICS
- Predicting new molecular targets for known drugs
- (2009) Michael J. Keiser et al. NATURE
- The future of drug development: advancing clinical trial design
- (2009) John Orloff et al. NATURE REVIEWS DRUG DISCOVERY
- Lessons from 60 years of pharmaceutical innovation
- (2009) Bernard Munos NATURE REVIEWS DRUG DISCOVERY
- Systems approaches and algorithms for discovery of combinatorial therapies
- (2009) Jacob D. Feala et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling
- (2008) Atilla Altinok et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
- Genome-wide association studies: progress and potential for drug discovery and development
- (2008) Stephen F. Kingsmore et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started